BBC expert gives major statins update about impact on health condition

Key Points:

• New research published in the British Journal of Ophthalmology suggests that taking cholesterol-lowering statins is associated with a 15% reduced risk of developing open-angle glaucoma over five years and a decreased need for intensive treatments or surgery.
• The study, involving over 210,000 statin users compared with a similar number of non-users in California, found that statin users had a 60% lower risk of undergoing selective laser trabeculoplasty (SLT) and an 11% lower risk of requiring eye drops to reduce eye pressure.
• Dr Oscar Duke emphasized that while the findings are promising, the study shows an association rather than a definite cause, and some research indicates long-term statin use might slightly increase glaucoma risk.
• More formal, randomized trials are needed to conclusively determine the effects of statins on glaucoma development and treatment, but statins are considered broadly safe and could potentially offer benefits beyond cholesterol lowering.
• Statins are widely used to reduce heart attack and stroke risk, and previous studies have suggested they might prevent or slow nerve cell death, though their impact on eye pressure and glaucoma remains unclear.